These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Allograft cytotoxicity. Two populations of effector cell detectable by cytolytic and cytostatic assays in vitro. Jones B, Jones TC, Roitt IM. Immunology; 1977 Apr; 32(4):591-9. PubMed ID: 415967 [Abstract] [Full Text] [Related]
46. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. Shimizu J, Suda T, Yoshioka T, Kosugi A, Fujiwara H, Hamaoka T. J Immunol; 1989 Feb 01; 142(3):1053-9. PubMed ID: 2464022 [Abstract] [Full Text] [Related]
48. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system]. Ebina T, Shishido K, Murata K. Gan To Kagaku Ryoho; 1990 Jul 01; 17(7):1345-50. PubMed ID: 2369138 [Abstract] [Full Text] [Related]
49. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease. Ohashi M, Kobayashi A, Hara H, Miura Y, Yoshida K, Kushida M, Ikarashi Y, Mandai M, Kitajima M, Yoshida T, Aoki K. Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2208-15. PubMed ID: 16609036 [Abstract] [Full Text] [Related]
59. [Antitumor effect of Cepharanthin in the double grafted tumor system]. Ebina T, Ishikawa K, Murata K. Gan To Kagaku Ryoho; 1990 Jun 01; 17(6):1165-71. PubMed ID: 2350192 [Abstract] [Full Text] [Related]